Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
arginine (1 trial)
hemin (Panhematin) (1 trial)
atazanavir (reyataz) (1 trial)
haloperidol (haldol) (2 trials)
lactic acid (1 trial)
olanzapine (zyprexa) (1 trial)
sodium chloride (1 trial)
Atherosclerosis (Phase 4)
Cardiovascular Diseases (Phase 4)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Trials (5 total)
Trial APIs (7 total)